Following drug response prediction with oncoPredict, Spearman correlation analysis was performed to identify the ubiquitination-related genes with a highly negative correlation to tamoxifen sensitivity in TCGA ER+ breast cancer cohorts (Fig. 7B). The gene discussed is ESR1; the disease is breast cancer.